C229H298F6N30O25 — CID 163927648
[4-[[4-[6-(dimethylamino)-3-pyridinyl]-2-pyridinyl]-[[4-(4-methoxy-3-methylphenyl)cyclohexyl]methyl]carbamoyl]cyclohexyl] 3-methylazetidine-1-carboxylate;[4-[[4-[2-(dimethylamino)pyrimidin-5-yl]-2-pyridinyl]-[[4-(4-methoxy-3-methylphenyl)cyclohexyl]methyl]carbamoyl]cyclohexyl] 3-methylazetidine-1-carboxylate;[4-[[4-(4-methoxy-3-methylphenyl)-1-bicyclo[2.2.2]octanyl]methyl-[4-(1-propan-2-ylpyrazol-4-yl)-2-pyridinyl]carbamoyl]cyclohexyl] 3-methylazetidine-1-carboxylate;[4-[[4-(4-methoxy-3-methylphenyl)cyclohexyl]methyl-[4-(5-propan-2-yl-1,2-oxazol-3-yl)-2-pyridinyl]carbamoyl]cyclohexyl] 3-methylazetidine-1-carboxylate;[4-[[4-(4-methoxy-3-methylphenyl)cyclohexyl]methyl-[4-[1-(trifluoromethyl)pyrazol-4-yl]-2-pyridinyl]carbamoyl]cyclohexyl] N-(2,2-dimethylbutyl)carbamate;[4-[[4-(4-methoxy-3-methylphenyl)cyclohexyl]methyl-[4-[1-(trifluoromethyl)pyrazol-4-yl]-2-pyridinyl]carbamoyl]cyclohexyl] 3-methylazetidine-1-carboxylate (PubChem CID 163927648) has the molecular formula C229H298F6N30O25 and a molecular weight of 3985.08 g/mol. Its IUPAC name is [4-[[4-[6-(dimethylamino)-3-pyridinyl]-2-pyridinyl]-[[4-(4-methoxy-3-methylphenyl)cyclohexyl]methyl]carbamoyl]cyclohexyl] 3-methylazetidine-1-carboxylate;[4-[[4-[2-(dimethylamino)pyrimidin-5-yl]-2-pyridinyl]-[[4-(4-methoxy-3-methylphenyl)cyclohexyl]methyl]carbamoyl]cyclohexyl] 3-methylazetidine-1-carboxylate;[4-[[4-(4-methoxy-3-methylphenyl)-1-bicyclo[2.2.2]octanyl]methyl-[4-(1-propan-2-ylpyrazol-4-yl)-2-pyridinyl]carbamoyl]cyclohexyl] 3-methylazetidine-1-carboxylate;[4-[[4-(4-methoxy-3-methylphenyl)cyclohexyl]methyl-[4-(5-propan-2-yl-1,2-oxazol-3-yl)-2-pyridinyl]carbamoyl]cyclohexyl] 3-methylazetidine-1-carboxylate;[4-[[4-(4-methoxy-3-methylphenyl)cyclohexyl]methyl-[4-[1-(trifluoromethyl)pyrazol-4-yl]-2-pyridinyl]carbamoyl]cyclohexyl] N-(2,2-dimethylbutyl)carbamate;[4-[[4-(4-methoxy-3-methylphenyl)cyclohexyl]methyl-[4-[1-(trifluoromethyl)pyrazol-4-yl]-2-pyridinyl]carbamoyl]cyclohexyl] 3-methylazetidine-1-carboxylate.
| Compound Name | [4-[[4-[6-(dimethylamino)-3-pyridinyl]-2-pyridinyl]-[[4-(4-methoxy-3-methylphenyl)cyclohexyl]methyl]carbamoyl]cyclohexyl] 3-methylazetidine-1-carboxylate;[4-[[4-[2-(dimethylamino)pyrimidin-5-yl]-2-pyridinyl]-[[4-(4-methoxy-3-methylphenyl)cyclohexyl]methyl]carbamoyl]cyclohexyl] 3-methylazetidine-1-carboxylate;[4-[[4-(4-methoxy-3-methylphenyl)-1-bicyclo[2.2.2]octanyl]methyl-[4-(1-propan-2-ylpyrazol-4-yl)-2-pyridinyl]carbamoyl]cyclohexyl] 3-methylazetidine-1-carboxylate;[4-[[4-(4-methoxy-3-methylphenyl)cyclohexyl]methyl-[4-(5-propan-2-yl-1,2-oxazol-3-yl)-2-pyridinyl]carbamoyl]cyclohexyl] 3-methylazetidine-1-carboxylate;[4-[[4-(4-methoxy-3-methylphenyl)cyclohexyl]methyl-[4-[1-(trifluoromethyl)pyrazol-4-yl]-2-pyridinyl]carbamoyl]cyclohexyl] N-(2,2-dimethylbutyl)carbamate;[4-[[4-(4-methoxy-3-methylphenyl)cyclohexyl]methyl-[4-[1-(trifluoromethyl)pyrazol-4-yl]-2-pyridinyl]carbamoyl]cyclohexyl] 3-methylazetidine-1-carboxylate |
|---|---|
| PubChem CID | 163927648 |
| Molecular Formula | C229H298F6N30O25 |
| Molecular Weight | 3985.08 g/mol |
| Exact Mass | 3982.29 |
| IUPAC Name | [4-[[4-[6-(dimethylamino)-3-pyridinyl]-2-pyridinyl]-[[4-(4-methoxy-3-methylphenyl)cyclohexyl]methyl]carbamoyl]cyclohexyl] 3-methylazetidine-1-carboxylate;[4-[[4-[2-(dimethylamino)pyrimidin-5-yl]-2-pyridinyl]-[[4-(4-methoxy-3-methylphenyl)cyclohexyl]methyl]carbamoyl]cyclohexyl] 3-methylazetidine-1-carboxylate;[4-[[4-(4-methoxy-3-methylphenyl)-1-bicyclo[2.2.2]octanyl]methyl-[4-(1-propan-2-ylpyrazol-4-yl)-2-pyridinyl]carbamoyl]cyclohexyl] 3-methylazetidine-1-carboxylate;[4-[[4-(4-methoxy-3-methylphenyl)cyclohexyl]methyl-[4-(5-propan-2-yl-1,2-oxazol-3-yl)-2-pyridinyl]carbamoyl]cyclohexyl] 3-methylazetidine-1-carboxylate;[4-[[4-(4-methoxy-3-methylphenyl)cyclohexyl]methyl-[4-[1-(trifluoromethyl)pyrazol-4-yl]-2-pyridinyl]carbamoyl]cyclohexyl] N-(2,2-dimethylbutyl)carbamate;[4-[[4-(4-methoxy-3-methylphenyl)cyclohexyl]methyl-[4-[1-(trifluoromethyl)pyrazol-4-yl]-2-pyridinyl]carbamoyl]cyclohexyl] 3-methylazetidine-1-carboxylate |
| SMILES | CCC(C)(C)CNC(=O)OC1CCC(C(=O)N(CC2CCC(c3ccc(OC)c(C)c3)CC2)c2cc(-c3cnn(C(F)(F)F)c3)ccn2)CC1.COc1ccc(C23CCC(CN(C(=O)C4CCC(OC(=O)N5CC(C)C5)CC4)c4cc(-c5cnn(C(C)C)c5)ccn4)(CC2)CC3)cc1C.COc1ccc(C2CCC(CN(C(=O)C3CCC(OC(=O)N4CC(C)C4)CC3)c3cc(-c4cc(C(C)C)on4)ccn3)CC2)cc1C.COc1ccc(C2CCC(CN(C(=O)C3CCC(OC(=O)N4CC(C)C4)CC3)c3cc(-c4ccc(N(C)C)nc4)ccn3)CC2)cc1C.COc1ccc(C2CCC(CN(C(=O)C3CCC(OC(=O)N4CC(C)C4)CC3)c3cc(-c4cnc(N(C)C)nc4)ccn3)CC2)cc1C.COc1ccc(C2CCC(CN(C(=O)C3CCC(OC(=O)N4CC(C)C4)CC3)c3cc(-c4cnn(C(F)(F)F)c4)ccn3)CC2)cc1C |
| InChI | InChI=1S/C40H53N5O4.C39H51N5O4.C38H50F3N5O4.C38H50N6O4.C38H50N4O5.C36H44F3N5O4/c1-27(2)45-25-32(22-42-45)31-12-19-41-36(21-31)44(37(46)30-6-9-34(10-7-30)49-38(47)43-23-28(3)24-43)26-39-13-16-40(17-14-39,18-15-39)33-8-11-35(48-5)29(4)20-33;1-26-23-43(24-26)39(46)48-34-14-10-30(11-15-34)38(45)44(37-21-32(18-19-40-37)33-13-17-36(41-22-33)42(3)4)25-28-6-8-29(9-7-28)31-12-16-35(47-5)27(2)20-31;1-6-37(3,4)24-43-36(48)50-32-14-11-28(12-15-32)35(47)45(34-20-30(17-18-42-34)31-21-44-46(23-31)38(39,40)41)22-26-7-9-27(10-8-26)29-13-16-33(49-5)25(2)19-29;1-25-22-43(23-25)38(46)48-33-13-10-29(11-14-33)36(45)44(35-19-31(16-17-39-35)32-20-40-37(41-21-32)42(3)4)24-27-6-8-28(9-7-27)30-12-15-34(47-5)26(2)18-30;1-24(2)35-20-33(40-47-35)31-16-17-39-36(19-31)42(23-27-6-8-28(9-7-27)30-12-15-34(45-5)26(4)18-30)37(43)29-10-13-32(14-11-29)46-38(44)41-21-25(3)22-41;1-23-19-42(20-23)35(46)48-31-11-8-27(9-12-31)34(45)43(33-17-29(14-15-40-33)30-18-41-44(22-30)36(37,38)39)21-25-4-6-26(7-5-25)28-10-13-32(47-3)24(2)16-28/h8,11-12,19-22,25,27-28,30,34H,6-7,9-10,13-18,23-24,26H2,1-5H3;12-13,16-22,26,28-30,34H,6-11,14-15,23-25H2,1-5H3;13,16-21,23,26-28,32H,6-12,14-15,22,24H2,1-5H3,(H,43,48);12,15-21,25,27-29,33H,6-11,13-14,22-24H2,1-5H3;12,15-20,24-25,27-29,32H,6-11,13-14,21-23H2,1-5H3;10,13-18,22-23,25-27,31H,4-9,11-12,19-21H2,1-3H3 |
| InChIKey | RFXCVYLQNNDBSH-UHFFFAOYSA-N |
| XLogP | 47.06 |
| TPSA | 565.25 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 43 |
| Rotatable Bonds | 55 |
| Heavy Atoms | 290 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3985.08 |
| LogP ≤ 5 | 47.06 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 43 |